Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | NPC1 | O15118 | 1/20 | 0.69 |
| ▸ | RAB9A | P51151 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 7/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.63 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.63 |
| ▸ | HDAC10 | Q969S8 | 6/20 | 0.63 |
| ▸ | NCOR2 | Q9Y618 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32664264 | 0.94 | L3MBTL1 (0.82) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL26496469 | 0.94 | L3MBTL1 (0.82) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL30555757 | 0.88 | MEN1 (0.72) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL30020550 | 0.88 | MEN1 (0.72) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL9167675 | 0.88 | MEN1 (0.72) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL8613820 | 0.86 | L3MBTL1 (0.69) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL8585803 | 0.86 | L3MBTL1 (0.69) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL7825577 | 0.85 | L3MBTL1 (1.00) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL4749309 | 0.85 | L3MBTL1 (0.76) | L3MBTL1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL11756426 | 0.85 | MEN1 (0.80) | L3MBTL1MEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210060014-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | CERENO SCIENTIFIC AB (SE) | 2021-03-04 | — | — | US | disclosed |
| US-20170020874-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | CERENO SCIENT AB (SE) | 2017-01-26 | — | — | US | disclosed |
| US-20140051716-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | CERENO SCIENTIFIC AB | 2014-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140051716-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC1, HDAC2 | L3MBTL1 1891/4885MEN1 4342/4885KMT2A 223/4885 |
| US-20170020874-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC1, HDAC2 | L3MBTL1 1891/4885MEN1 4342/4885KMT2A 223/4885 |
| US-20210060014-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC1, HDAC2 | L3MBTL1 1891/4885MEN1 4342/4885KMT2A 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.